John Oyler - Jan 10, 2023 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Jan 10, 2023
Transactions value $
-$5,067,449
Form type
4
Date filed
1/12/2023, 03:52 PM
Previous filing
Dec 29, 2022
Next filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE American Depositary Shares Sale -$217K -879 -12.93% $247.00 5.92K Jan 10, 2023 Direct F6, F7, F8
transaction BGNE American Depositary Shares Sale -$605K -2.44K -41.26% $247.74 3.48K Jan 10, 2023 Direct F6, F7, F9
transaction BGNE American Depositary Shares Sale -$332K -1.34K -38.43% $248.76 2.14K Jan 10, 2023 Direct F6, F7, F10
transaction BGNE American Depositary Shares Sale -$487K -1.95K -91.03% $249.84 192 Jan 10, 2023 Direct F6, F7, F11
transaction BGNE American Depositary Shares Sale -$48.1K -192 -100% $250.26 0 Jan 10, 2023 Direct F6, F7, F12
transaction BGNE American Depositary Shares Sale -$217K -879 -12.93% $247.00 5.92K Jan 10, 2023 See Footnote F3, F6, F8, F13
transaction BGNE American Depositary Shares Sale -$605K -2.44K -41.26% $247.74 3.48K Jan 10, 2023 See Footnote F3, F6, F9, F13
transaction BGNE American Depositary Shares Sale -$332K -1.34K -38.43% $248.76 2.14K Jan 10, 2023 See Footnote F3, F6, F10, F13
transaction BGNE American Depositary Shares Sale -$487K -1.95K -91.03% $249.84 192 Jan 10, 2023 See Footnote F3, F6, F11, F13
transaction BGNE American Depositary Shares Sale -$48.1K -192 -100% $250.26 0 Jan 10, 2023 See Footnote F3, F6, F12, F13
transaction BGNE American Depositary Shares Sale -$217K -879 -12.93% $246.97 5.92K Jan 10, 2023 See Footnote F4, F6, F8, F13
transaction BGNE American Depositary Shares Sale -$605K -2.44K -41.26% $247.74 3.48K Jan 10, 2023 See Footnote F4, F6, F9, F13
transaction BGNE American Depositary Shares Sale -$332K -1.34K -38.43% $248.76 2.14K Jan 10, 2023 See Footnote F4, F6, F10, F13
transaction BGNE American Depositary Shares Sale -$486K -1.95K -90.98% $249.84 193 Jan 10, 2023 See Footnote F4, F6, F11, F13
transaction BGNE American Depositary Shares Sale -$48.3K -193 -100% $250.26 0 Jan 10, 2023 See Footnote F4, F6, F12, F13
holding BGNE Ordinary Shares 1.62M Jan 10, 2023 Direct
holding BGNE Ordinary Shares 482K Jan 10, 2023 See Footnote F1
holding BGNE Ordinary Shares 7.73M Jan 10, 2023 See Footnote F2
holding BGNE Ordinary Shares 29M Jan 10, 2023 See Footnote F3
holding BGNE Ordinary Shares 9.55M Jan 10, 2023 See Footnote F4
holding BGNE Ordinary Shares 102K Jan 10, 2023 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
F2 These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
F3 These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
F4 These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
F5 These securities are held by The John Oyler Legacy Trust, of which the Reporting Person's father is a trustee, for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.
F6 Each American Depositary Share represents 13 Ordinary Shares.
F7 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2022.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.21 to $247.20, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.21 to $248.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.23 to $249.22, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.23 to $250.19, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.26 to $250.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F13 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2022.